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Ly-1 inducer T  cells play a critical role in the regulation of antibody synthesis. 
One subset of Ly- 1 T  inducer cells (Qa- 1-) can activate B lymphocytes to secrete 
IgM (1).  A second (Qa-1 +) stimulates Ly-l,2  + T  cells to differentiate into Ly-2  + 
T  suppressor cells (1-3) that inactivate both subsets of inducer T  cells, resulting 
in reduced levels of antibody formation and suppression. 
Recent  reports  (4-7)  have  indicated  that  T  cells can  also  inhibit  antibody 
responses without induction of Ly-2 T  suppressors.  Heterogeneous or cloned 
Ly-1 T  cells failed to function as T  helper (Th) 1 cells and inhibited primary IgM 
responses. This reflected direct inhibition of B cell maturation into IgM-secreting 
cells by the Ly-l:Qa-1 + fraction of inducer cells (4,  5).  The nonhelper Ly-1  T 
cell induced B cell proliferation but inhibited primary IgM response to phos- 
phorylcholine-ovalbumin (PC-OVA): suppression was I-A-restricted and required 
a hapten-carrier bridge between the B cell and the Ly-1 T cell clone (5). Inhibition 
of secondary responses with some nonhelper Ly-1 ÷ T  cells (6, 7) has also been 
observed. In this case, T  cell clones prevent an antigen-specific, major histocom- 
patibility complex (MHC)-restricted interaction between carrier-specific Th cells 
and B cells. 
In the present study, we further analyzed the mechanism of inhibition of B 
cell responses in vitro, using Ly-1  T  cell clones. We found that two Ly-1  T  cell 
clones did not induce B cells to secrete antigen-specific IgG. Instead, these clones 
inhibited secretion of IgG antibody to T-dependent soluble antigens. Inactivation 
of the B cell occurred early and required cell-cell contact that is both I region 
restricted and antigen specific, resulting in  an early proliferative response by 
antigen-specific memory B  cells,  without subsequent differentiation into  anti- 
body-secreting cells. 
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Materials and  Methods 
Animals 
Female  BALB/cByJ,  A/J,  DBA/2J,  B10.A/SgSnJ,  B10.D2nSnJ,  (BALB/cJ  ×  A/J)F~ 
(CAFI),  and  (BALB/c  ×  DBA/2)F1  (CD2F1)  mice  were  obtained  from  The Jackson 
Laboratory, Bar Harbor, ME,  B10.GD mice were kindly provided by Dr.  Martin  Dorf 
(Harvard Medical School, Boston, MA) and (B10.A ×  B10.D2)F~  mice were bred in our 
colony at the Dana-Farber Cancer Institute. All mice were between the age of 2-6 too. 
Antigens 
Dinitrophenylated  (DNP)  proteins  were  prepared  using  conditions  favoring a  low 
coupling ratio:  DNP.~OVA  and DNPsKLH (Keyhole limpet hemocyanin) (per  100  kilo- 
daltons)  (8).  Arsanylated  (ARS)  proteins  were  prepared  as  described  previously  (9); 
haptenation  ratios (moles [Ars-Tyr +  Ars-His]/mole protein)  were estimated using an 
extinction coefficient of 8.15 mM  -j in 0.1  N NaOH at the isobestic point of 350 mm (9, 
10). The haptenation ratios of the antigens used were ARS4OVA, DNPsOVA ARS4, and 
ARSsKLH (per 100 kD). 
Immunization 
Mice were primed to DNP-KLH, DNP-OVA, orARS-KLH by intraperitoneal injection 
of 10 ug of antigen and 4 mg of alum. 3-4 wk later the mice were boosted with 10 #g of 
antigen in saline and used at 1-12 wk after the second immunization. 
Antisera 
Murine  monoclonal anti-Thy-l.2 was kindly donated by Dr.  Ed Clark (University of 
Washington,  Seattle,  WA).  Murine  monoclonal  anti-Ly-l.2  and  -Ly-2.2  were  kindly 
donated by Dr. F. W. Shen (Memorial Sioan-Kettering Cancer Center). Rat monoclonal 
anti-Ly-1, anti-Ly-2, and anti-Thy-1 antibodies were purchased from Becton, Dickinson 
& Co. (Mountain View, CA). Antibodies from hybridomas 14-4-4S (I-Ed'k'PX:Ia.7)  and MK- 
D6 (I-Ad'q:Ia. 16) were purified from culture supernatants using protein A-Sepharose or 
DEAE cellulose.  Purified  monoclonal antibody  H7-8.26  (7A)  [I-Ed'k'v'r:Ia.7(2)] was ob- 
tained from Dr. Chella David (Mayo Medical School, Rochester, MN). 
Derivation  of Ly-I T Cell Clones 
Ly-l-03.  After  BALB/cByJ  mice  were  injected  with  50  t~g  of OVA  in  complete 
Freund's adjuvant H37RA (Difco Laboratories, Inc., Detroit, MI) in  the hind footpads 
and tail base; clones were derived as described previously (10).  Briefly, wells were seeded 
at 1 and 0.3 cells/well, expanded, and tested for OVA specificity by a proliferation assay. 
OVA-specific T cell lines were recloned and expanded from wells seeded at 0.3 cells/well. 
The cloned T  cell line has been maintained as follows: 2 ×  105 Ly-l-03 are stimulated, 
every 5 wk, with adherent cells  from 5  ×  106 irradiated  (2,500  rad) syngeneic BALB/ 
cByJ  spleen  cells  pulsed  with  1.0  ~g/ml  OVA  (see  below),  followed  by expansion  in 
Dulbecco's modified Eagle's medium (DME) containing 10% fetal calf serum (FCS),  20% 
interleukin  1 (IL-1), and 1% IL-2. 
Ly-l-Ar-5.  The derivation and maintenance of the ARS-specific T  cell line Ly-l-Ar-5 
has been described previously (10).  Briefly, spleens were removed 18 d after intraperito- 
heal immunization of CAF~ mice with  100 ~g ARS-KLH in complete Freund's adjuvant. 
The spleen  cell cultures  were enriched  for ARS-reactive T  cells  by stimulating weekly 
with  50 ~g/ml ARS-BGG (bovine gamma globulin) and irradiated CAF~ spleen cells in 
complete medium. At 4 wk the cultures were cloned as described above. 
Both T  cell clones expressed surface glycoproteins Thy-1, Ly-1, but not  Ly-2 when 
assayed by fluorescence staining with antibody. In all assays, the T  cell clones were used 
at least 2 wk after activation with antigen-pulsed adherent cells. 
Antigen-specific Proliferation  Assay 
Cloned Ly-1  T  cells were added to microwells (3040;  Falcon Labware, Oxnard CA) 
containing irradiated syngeneic BALB/cByJ spleen cells in complete DME with 5% FCS FRIEDMAN ET  AL.  787 
and the indicated antigen. [3H]Thymidine incorporation was assayed on day 2 by pulse 
labeling cells at 24 h with 1 ~,Ci [3H]thymidine (New England Nuclear, Boston, MA) and 
culturing for an additional 18 h. Results are expressed as mean counts per minute (cpm) 
of triplicate cultures. 
Preparation of Enriched B or Ly-I Cells 
B cells plus accessory cells were purified by adherence of whole spleen cells (3 x  107) 
to petri dishes (1029; Falcon Labware) coated with goat anti-mouse IgM (11). Nonadher- 
ent cells  were removed by several washes  in  Cantor's balanced salts  (Irvine Scientific, 
Santa Ana, CA) containing 0.1% bovine serum albumin (BSA). The adherent cells were 
dissociated from the dishes by vigorous pipetting. To eliminate contaminating T cells, the 
eluted cells were incubated with monoclonal anti-Thy-l.2, anti-Ly-l.2, and anti-Ly-2.2 
antibodies, plus rabbit complement, for 45 min at 37°C. To prepare Ly-l-enriched cells, 
the nonadherent cells from the goat anti-mouse IgM-coated petri dishes were incubated 
on rat anti-Ly-1-coated petri dishes (12), eluted, and treated with monoclonal anti-Ly-2.2 
and rabbit complement. Populations of both enriched B cells (92%  Ig  +) and Ly-1 cells 
(93% Ly-1 ÷) still contained accessory cells. 
t~rified B Cells 
B cells plus accessory cells  (purification described above) were depleted of adherent 
cells by passage over Sephadex G 10 columns (13). 
Adherent and Antigen-pulsed Adherent Cells 
To prepare adherent,  antigen-presenting cells,  2.5  x  10  ~ nonimmune whole spleen 
cells were incubated for 60-90 min in microtiter wells (3040; Falcon Labware) in complete 
DME medium containing 10%  FCS at 37°C. To prepare antigen-pulsed adherent cells, 
antigen was included during the 60-90 min incubation period. To deplete cultures of 
nonadherent cells,  the microtiter wells  were washed by vigorous pipetting with  fresh 
medium at least five times. 
Miniature  Mishell-Dutton Cultures 
Immune spleen cells (106) or B cells (6 X 10  ~) with or without immune Ly-1 T cells (2.5 
x  10  ~)  were  cultured  in  microtiter wells  (3040;  Falcon  Labware)  in  complete  DME 
supplemented with  10%  FCS,  100 U/ml penicillin, 100 ~,g/ml streptomycin, 0.3% Fun- 
gizone (Gibco Laboratories, Grand  Island,  NY)  (14).  A  pool of triplicate cultures was 
assayed for hemolytic plaque-forming cells  (PFC)  by modification of the Jerne plaque 
technique (15), using trinitrophylated sheep red blood cells (TNP-SRBC) (16) or arsany- 
lated  SRBC  (ARS-SRBC)  (17).  In  response  to  DNP-proteins,  the  PFC  assay  detects 
antibody that is crossreactive with TNP. To develop total PFC, rabbit anti-mouse Fc of 
IgG was added to the complement; IgG PFC were calculated as total PFC minus direct 
PFC (IgM) (18). The avidity of the IgM or IgG PFC was determined by hapten inhibition 
(19). In response to DNP-KLH or DNP-OVA, IgG anti-DNP PFC were 90-95% inhibited 
by 10  -~ M DNP-lysine. 
Results 
Activation of Ly-1  T Cell Clones 
Antigen specificity.  The response of the OVA-specific clone Ly-l-03 to OVA 
was  detectable  at  0.01  #g/ml  and  maximal  at  1  ~g/ml.  The  clone  was  also 
activated by hapten conjugates of OVA such as DNP-OVA, ARS-OVA, or DNP- 
OVA-ARS, and maximal responses to the latter required  10-fold lower concen- 
trations  than  to  conjugated  OVA.  Clone  Ly-l-03  recognized  OVA  and  not 
hapten determinants on the conjugates, since DNP-KLH and ARS-KLH did not 
stimulate responses even at high concentrations (Fig.  1 A  and data not shown). 788  B CELL-Ly-1 T  CELL INTERACTION  INHIBITS  lgG  RESPONSES 
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FIGURE  1.  Antigen  dose curve and specificity  of the activation of the T cell clones. (A) To 
5 × 10  "~ irradiated (2,500 rad) BALB/cByJ  spleen cells, 104 clone Ly-l-03 cells were added in 
the presence of increasing concentrations of DNP-OVA (DO), ARS-OVA (AO), DNP-OVA- 
ARS (DOA), OVA, or DNP-KLH  (DK). (B) To 5 × 105 irradiated CAFI spleen cells, 104 clone 
Ar-5 cells were added in the presence of increasing concentrations of DNP-OVA-ARS, ARS- 
KLH (AK), ARS-OVA, DNP-KLH,  or DNP-OVA. [SH]Thymidine  incorporation was assayed 
on day 2, as described in Materials  and Methods. 
The  ARS-specific clone,  Ly-l-Ar-5, responded to  ARS-OVA,  ARS-KLH, and 
DNP-OVA-ARS,  and  did  not  respond  to  DNP-KLH  and  DNP-OVA.  [3H]- 
Thymidine incorporation was detectable after stimulation by 0.10 ug/ml ARS- 
KLH and DNP-OVA-ARS  or  1.0 ug/ml ARS-OVA;  it was maximal at  1.0 ~g/ 
ml ARS-KLH and DNP-OVA-ARS, and 10 #g/ml ARS-OVA (Fig.  1B). 
Antigen-presenting  cells.  Clone  Ly-l-03 responded to OVA presented by ir- 
radiated  whole  spleen  cells,  purified  B  cells,  and  pulsed  or  unpulsed  splenic 
adherent  cells  (Fig.  2A)  (20).  At  1.0  ~g/ml  OVA,  spleen  cells  were  twice  as 
efficient as either  purified  B  cells  or adherent cells  in  presenting antigen;  at 
higher  concentrations  of antigen  (e.g.,  10  /~g/ml),  there  was  no  difference 
between the three cell populations (data not shown). Similarly, we found that all 
of the above cell types can present arsanylated proteins to clone Ly-l-Ar-5. 
Genetic restriction.  The response to OVA by clone Ly-l-03 required recogni- 
tion of I-A  s. B10.D2 and B10.GD but not B10.A spleen cells presented OVA to 
clone Ly-l-03 (Fig. 2B). The resulting proliferative response was inhibited only 
by monoclonal anti-I-A  s  (MK-D6) and not by anti-I-E  a [H7-8.26(7A),  14-4-4S] 
(not  shown).  Clone  03  also  responded  to  OVA  presented  by  F~  strains  like 
(BALB/cJ  ×  A/J)FI  (CAFI)  and  (B10.A  X  B10.D2)  (Fig.  2B).  Similarly,  the 
CAFl-derived  clone  Ly-l-Ar-5  responds  to  arsanylated  protein  in  association 
with I-A  d on antigen-presenting cells from CAFI, parent BALB/cJ, but not A/J 
(10,21). 
Both T  cell clones produce factors typical of Ly-l + cells.  Both T  cell clones are 
Thy- 1  +, Ly-1 +,  Ly-2- and, after stimulation with antigen-pulsed adherent cells, 
produce several proliferation and differentiation factors: IL-2, IL-3, and B cell 
growth  factors,  BCGF-1  and  BCGF-2,  (data  not shown;  and  22,  23).  Ly-l-03 FRIEDMAN  ET  AL.  789 
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FIGURE 2.  (A) Comparison of the ability of different cell populations to present OVA to Ly- 
1-03.  Increasing number of whole spleen (O),  B cells (A),  or adherent (O  O) cells were 
cultured with 2.5  x  104 clone Ly-l-03 cells and  1.0 #g/ml OVA.  All cell populations were 
irradiated with 1,000 rad. Adherent cells, pulsed with 1.0 pg/ml OVA for 60 min (described 
in Materials and Methods), were washed extensively and then incubated with only 2.5 x  104 
Ly-l-03  (O---C)).  (B) Genetic restriction of activation. 2.5  x  104 clone Ly-l-03 cells were 
incubated  with  5  ×  105  irradiated  (2,500  rad)  spleen  cells of the  indicated  strains.  [SH]- 
Thymidine incorporation was measured on day 2. 
produces  B  cell  differentiation  factors  (BCDF)  required  for  IgM  anti-SRBC 
response, anti-p polyclonal stimulation of IgM reverse plaques, and the induction 
of K light chain synthesis in the pre-B cell line 70Z/3 (Ly-l-03) (data not shown; 
and 24-26). Ly- 1-Ar-5 produces macrophage-activating factor (10). 
Ly-1  T Cell Clones Specifically Inhibit Ig Secretion of B Cells 
Despite their production of B cell growth factors and B  cell differentiation 
factors, clones Ly-l-03 and Ar-5  do not induce B cells to secrete antibody to 
protein antigens: Ly-l-03 did not stimulate primary or secondary DNP-specific 
B cells to secrete Ig in cultures activated with DNP-OVA. Clone Ly-l-Ar-5 did 
not stimulate primary or secondary DNP- or ARS-specific B cells to secrete Ig to 
either hapten  in  cultures activated by  DNPoOVA-ARS or ARS-OVA,  respec- 
tively. Varying the activation state of both the immune B cells and the Ly-1  T 
cell clones, and varying the time of addition of Ly-1 T cells did not induce helper 
function in these Ly-1 T  cell clones. The addition of second signals:  lipopolysac- 
charide (LPS) (27), virgin or immune T  cells (28), lymphokine-containing super- 
natants from concanavalin A (Con A)-stimulated spleen cells (29), or antigen- or 
Con A-stimulated T  cell clones (30), to cultures containing immune B cells plus 
Ly-1 T  cells, failed to induce antigen-specific Ig secretion (data not shown). 
Therefore, we tested the possibility that these Ly-1  cloned T  cells inhibited 
differentiation of antibody-secreting B  cells.  Addition of  104  Ly-l-03  cells to 
DNP-OVA-immune spleen cells incubated with DNP-OVA completely inhibited 
the secondary IgG anti-DNP PFC response. Inhibition was antigen specific, since 
Ly-l-03 did not significantly affect the IgG PFC response of DNP-KLH-primed 
spleen  cells  in  DNP-KLH-stimulated  cultures  (Table  I).  Similarly,  the  ARS- 
specific clone Ar-5  inhibited  secondary IgG  anti-ARS  PFC  response in  ARS- 790  B  CELL-Ly-1  T  CELL  INTERACTION  INHIBITS  IgG  RESPONSES 
TABLE  I 
Inhibition of lgG PFC Response by Ly-1 T Cell Clones Is Antigen 
Specific 
Anti-hapten 
Group  lgG PFC  Percent inhibition 
DNP-OVA  3,791 
DNP-OVA + Ly-l-03  0  100 
DNP-KLH  3,248 
DNP-KLH + Ly-l-03  3,106  4 
ARS-KLH  1,245 
ARS-KLH +  Ly-l-Ar-5  300  76 
DNP-KLH  1,178 
DNP-KLH +  Ly-l-Ar-5  1,238  0 (+5) 
l04 irradiated clone 03 or Ar-5 cells were added to 106 spleen cells from 
immune  mice  and  the  cultures were  stimulated with  the  immunizing 
antigen as indicated, lgG anti-hapten (DNP or ARS) PFC response was 
quantitated on day 5. 
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FIGURE 3.  Cell number and antigen concentration required for inhibition. (A) Increasing 
numbers  of clone  Ly-l-03 T  cells,  either  nonirradiated (  )  or  irradiated (2,500  rad) 
(_ _ _), were added to cultures of 10  ~ DN P-OVA immune BALB/cByJ spleen cells restimulated 
with 0.01  #g/ml of DNP-OVA. (B) In the same experiment, 10  ~ DNP-OVA-immune spleen 
cells  were  restimulated  with  increasing  concentrations  of  DNP-OVA,  in  the  presence 
(0---0)  or absence of (O  O)  104 irradiated Ly-l-03. Both sets of cultures were assayed 
for igG anti-DNP PFC response on day 6. 
KLH-stimulated  cultures,  and  did  not  inhibit  IgG  anti-DNP  PFC  response  in 
DNP-KLH-stimulated  cultures (Table I). 
Conditions for inhibition.  To  determine  the number  of inducer cells required 
for  inhibition,  increasing  numbers  of Ly-l-03  (10  to  104  cells) were  added  to 
cultures stimulated with  0.01  ~g/ml  DNP-OVA.  Significant inhibition was seen 
with  as  few  as  10-100  Ly-l-03  cells;  maximal  inhibition  (95-100%)  occurred 
when  5  X  103  to  104  cells were  added.  Irradiation  of the  T  cell clone slightly 
decreased its ability to inhibit the PFC response to DNP-OVA  (Fig. 3A). 
DNP-OVA-immune  spleen cell cultures were stimulated in vitro with increas- 
ing concentrations of DNP-OVA,  from 0.001  to  10 ug/ml.  The  addition of 104 FRIEDMAN  ET  AL.  791 
irradiated (Fig. 3B) or nonirradiated (data not shown) clone Ly-l-03 cells caused 
75-100%  inhibition  of the IgG anti-DNP response at all concentrations tested. 
Inhibition was maximal (92%) at 0.001 eg/ml DNP-OVA, 100-fold less than that 
required to induce optimal DNA synthesis (Figs. 3B and  1A). 
Cellular Mechanisms of Inhibition 
Ly-2 T suppressors are not required for inhibition.  Previous analysis (1-3) of Ly- 
1 induction of suppression showed that these cells activate Ly-2 T  suppressors in 
vitro  which,  in  turn,  inactivate  Ly-1  T  helper  activity.  We  therefore  tested 
whether  inhibition  by  clones  03  and  Ar-5  required  antigen-specific  Ly-2  T 
suppressors. 
B cells from DNP-immune donors were incubated with OVA-specific Ly-1 Th 
cells,  and  DNP-OVA  or  DNP-OVA-ARS.  When  Ly-l-03  was added  to  these 
cultures,  the  IgG PFC  response was completely inhibited  (Fig.  4  and data not 
shown). The ARS-specific Ly-1 T  cell clone Ar-5 slightly enhanced the IgG anti- 
DNP  PFC response  in  B plus Ly-1  cultures  stimulated  with  DNP-OVA,  while 
completely inhibiting PFC responses in cultures stimulated with DNP-OVA-ARS 
(not shown). Since these cultures did not contain detectable numbers of Ly-2  ÷ T 
cells, we conclude that the induction of Ly-2  ÷ T  suppressors is not the predomi- 
nant mechanism of inhibition by these two Ly-1 T  cell clones. 
Direct inactivation of B cells.  There are at least two remaining mechanisms by 
which an  Ly-1  T  cell  clone can  inhibit  IgG responses:  the  clone  may directly 
inactivate B cells or functionally delete Ly-1 Th cells. To differentiate between 
these two mechanisms  we used antigens  that  had activating determinants  both 
for the clones (i.e., OVA or ARS) and for either the DNP-specific B cells or the 
appropriate  carrier-specific  Th cells also present in the cultures.  This tests the 
probable cellular  target  of inhibition,  by focusing the  Ly-1  T  cell clones onto 
either B cells or Th cells, respectively. 
The  relative  role  of  the  above  mechanisms  was  analyzed  in  the  T  cell- 
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FIGURE 4.  Inhibition of B plus Ly- 1 cultures by Ly- 1-03 in response to DNP-OVA. Increasing 
numbers of irradiated cloned T  ceils 03 (0) and At-5 (@) were added to cultures containing 
purified B cells,  Ly-1  cells, accessory cells, and 0.01  #g/ml  DNP-OVA.  IgG anti-DNP PFC 
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dependent and MHC-restricted IgG PFC response to DNP-KLH in BALB/c and 
CAF~  mice. The IgG response was MHC restricted rather than dependent on 
nonspecific factors. The PFC response was inhibited by anti-class II (I-A,  I-E) 
antibodies, and supernatants from Con A-stimulated cells did not induce signif- 
icant IgG secretion by purified DNP-KLH-immune B cells (29). To test whether 
inhibition  was  effective  when  the  Ly-1  clone  was  focused  onto  B  cells,  we 
compared the ability of Ly-l-03 to inhibit DNP-KLH responses in the presence 
of DNP-OVA and OVA.  These two antigens were almost equivalent in  their 
ability to activate the clone (Fig.  1A), but only DNP-OVA was capable of also 
binding to DNP-specific B cells from DNP-KLH-immune mice. 
DNP-KLH-immune spleen cells were stimulated with increasing concentrations 
of OVA or DNP-OVA (0.001-10 #g/mi) in the presence or absence of 10 4 Ly- 
1-03 T  cells. The IgG anti-DNP response was 75% inhibited in cultures contain- 
ing 0.001 •g/ml  DNP-OVA plus 104 Ly-1-03, and completely inhibited by 0.01- 
0.1  #g/ml  DNP-OVA  plus  10 4  Ly-l-03.  In  contrast,  inhibition  in  cultures 
containing OVA was significant (86%) only at 1 t~g/ml (Fig. 5A). Thus, although 
DNP-OVA was only 10-fold more efficient than OVA in activation of Ly-l-03 
(0.1  vs.  1.0  ~g/ml,  respectively;  Fig.  1A),  DNP-OVA  was  1,000-fold  more 
efficient than OVA in inhibiting IgG anti-DNP responses (Fig. 5A). 
This result suggests that  inhibition by clone Ly-l-03,  like help mediated by 
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FIGURE 5.  Antigen-specific interaction between Ly-l-03 and B cells is required for inhibition 
of lgG secretion. (A) 106 DNP-KLH-immune BALB/c spleen cells were stimulated with 0.10 
#g/ml of DNP-KLH and increasing concentrations of OVA or DNP-OVA in the presence or 
absence of 104 clone Ly-l-03 cells.  (B) Antigen-pulsed adherent cells present DNP-KLH  to 
Ly-1-03 and B cells. DN P-KLH-immune BALB/c spleen cells were depleted of most adherent 
cells by two sequential incubations of 5 ×  106 spleen cells/ml for 90 rain on petri dishes (Falcon 
3003,  100  x  20  mm).  106  cells  of the  nonadherent immune  population  were  added  to 
microwells containing adherent cells from 2.5 ×  105 nonimmune spleen cells and the cultures 
were activated with 0.10 #g/ml DNP-KLH.  One set of cultures contained adherent cells that 
were pulsed with increasing concentrations of DNP-OVA  for 90  min.  In the second set of 
cultures, the adherent cells were not pulsed with antigen; increasing concentration of soluble 
DNP-OVA was added along with 0.10 #g/ml DNP-KLH to the immune spleen cells. To both 
groups,  104 irradiated Ly-l-03 was added at time 0. lgG anti-DNP PFC were assayed on day 
6. FRIEDMAN ET AL.  793 
Ly-1 T  cells, is most effective if the clone makes contact with B cells through an 
antigen bridge. Again, as in Th and B cell interactions, the antigen bridge can 
be  mediated by  antigen-pulsed  adherent  cells (31).  Spleen  cells (depleted of 
adherent cells) from DNP-KLH-immune BALB/c mice were added to cultures 
containing adherent cells from nonimmune BALB/c mice pulsed with increasing 
concentrations of DNP-OVA. The cultures that contained adherent cells pulsed 
with 0.10 gg/ml DNP-OVA and 104 Ly-l-03 were 99% inhibited. The inhibition 
was equivalent to cultures that had soluble DNP-OVA and Ly-l-03 added in the 
beginning of the culture period (Fig. 5B). 
Ly-I T cell clone and Ly-I Th interaction.  In addition to the direct inactivation 
of B ceils described above, it was also possible that the Ly-1  T  cell clones could 
interact with and functionally inactivate the Ly-1  Th cells required for B  cell 
maturation (32). This possibility was directly tested: Ly-l-Ar-5 cells were added 
to cultures containing DNP-KLH-immune spleen cells, and were stimulated with 
DNP-KLH  as well as either DNP-OVA-ARS,  to  focus the clone onto  B  cells 
(controls  DNP-OVA  and  ARS-OVA),  or  ARS-KLH  (control  ARS-OVA),  to 
focus the clone onto carrier-specific Th cells. 
Clone Ly-l-Ar-5 behaved similarly to clone Ly-l-03, in that B cell-directed 
antigens were more effective at  inhibiting a  DNP-KLH  response.  DNP-OVA- 
ARS elicited 50%  inhibition at 0.001  #g/ml and 95%  inhibition at 0.01-0.10 
#g/ml, in cultures containing  10  4 Ly-l-Ar-5 (Fig. 6A). The non-B-cell-directed 
antigen control, ARS-OVA, was  1,000-fold less  effective, since it elicited only 
50% inhibition at 1 ug/ml (Fig. 6B). 
To  focus  Ly-l-Ar-5  T  cells  onto  KLH-specific  Ly-1  Th  cells,  increasing 
? 
o 
x 
g 
40 
35 
30 
25 
20 
15 
A. 
.',,,. 
I /  \'\~...~.\ 
-i~a.~..~e  OOA*Ar-5 
i  J  I  i 
O.OOt  0.01  0.1  t  10 
B. 
\ 
I  ~#  DOA+Ar-5 
0.001  0.01  0.1  1 
Antigen Concentration, pg/ml 
FIGURE 6.  The interaction of clone Ar-5 with B cells, but not with Ly-1  Th cells, inhibits 
IgG secretion. (A) 10  6 CAFI immune spleen cells were stimulated with 0.10 gg/ml DNP-KLH 
in the presence or absence of 10 4 clone Ly-1-Ar-5 cells and increasing concentrations of DNP- 
OVA or DNP-OVA-ARS. (B)  10  6 immune CAF~ spleen cells, treated twice with anti-Ly-2, 
were activated with 0.10/~g/ml DNP-KLH. To the cultures were added increasing concentra- 
tions of DNP-OVA-ARS, ARS-OVA, or ARS-KLH, with 10  4 Lys-l-Ar-5. IgG anti-DNP PFC 
were assayed on day 6. The addition of antigens alone had no effect on the anti-DNP PFC 
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concentrations  of  ARS-KLH  were  added  to  anti-Ly-2.2-treated  DNP-KLH- 
immune spleen cells. If one component of inhibition requires an antigen-specific 
interaction  between the Ly-1 T  cell clone Ar-5 and KLH-specific Th cells, then 
ARS-KLH should  be comparatively  more  efficient at  eliciting  inhibition  than 
ARS-OVA. However, we detected no difference between ARS-KLH and ARS- 
OVA, even though cultures contained KLH-specific Th cells. PFC responses in 
cultures containing ARS-KLH and ARS-OVA were ~educed 50% at  1 gg/ml, in 
the presence of 104 clone Ly-l-Ar-5 cells (Fig. 6B). In the same experiment, the 
antigen DNP-OVA-ARS, which focuses the clone onto DNP-specific B cells, was 
1000-fold  more  efficient  than  either  ARS-KLH  or  ARS-OVA,  as  described 
above (Fig.  6B). The more potent inhibition  by DNP-OVA-ARS vs. ARS-KLH 
or ARS-OVA cannot be explained  by differential activation of the clone, since 
dose response curves for all the antigens are very similar (Fig.  1 B). We conclude 
that  Ly-l-Ar-5,  like clone Ly-l-03, may inhibit  by directly inactivating  B cells, 
and that  inactivation  of KLH-specific Th cells by clone Ly-l-Ar-5 is unlikely to 
be the predominant  mechanism of inhibition. 
Antigen-specific Interaction Between the Cloned T Cells and B Cells Is I-A d 
Restricted 
Next we del~ermined the genetic restriction of the antigen-specific interaction 
between the cloned T  cells and B cells. 104 irradiated Ly-l-03 T  cells were added 
with  DNP-OVA to  DNP-KLH-stimulated  immune  spleen  cells of the  relevant 
strains  of mice.  When  necessary, the clone was activated with  the appropriate 
(BALB/c X A/J)F~  or (B10.A  X  B10.D2)F~  antigen-presenting  adherent  cells. 
The clone (which is I-A  d restricted) inhibited IgG anti-DNP responses of BALB/ 
c, B10.D2, and B10.GD immune spleen cells, but did not inhibit  IgG anti-DNP 
responses of A/J or B10.A immune spleen cells. We conclude that the inhibition 
of B  cell  secretion  by Ly-l-03  is  I-A  d restricted  (Table  II).  Similarly,  we have 
shown that the inhibition  of B cell secretion by the hapten-specific T  cell clone 
Ar-5 is I-A  d restricted (data not shown). 
It is noteworthy that recognition of one parental MHC molecule (I-A  d) by both 
the BALB/c-derived clone Ly-l-03 and the CAF~-derived clone Ar-5 was suffi- 
cient to inhibit the entire response of CAF1 mice, provided that the appropriate 
B  cell-directed  antigens  (DNP-OVA  or  DNP-OVA-ARS  for  clone  03,  DNP- 
OVA-ARS for clone Ar-5) were also present in the cultures (data not shown and 
Fig. 6A). We have determined by inhibition  with specific anti-Ia antibodies that 
the  DNP-KLH-immune  spleen  cells from  CAF1  mice contain  similar  levels of 
helper activity for B cells bearing any of the four I region-coded molecules:  I- 
A k, I-E  k, I-A  a, and I-E  d (data not shown). 
Unlike the T-T interaction that generates suppression (3), interaction between 
the cloned T  cells and B cells is not Ig-H restricted; the addition of either T  cell 
clone inhibited  IgG anti-DNP  PFC  in  both  BALB/c allotype-congenic strains, 
C.AL/20 (Ig-V) and C.B20 (Ig-I b) (data not shown). 
Kinetics of Inhibition 
To test if the clone inhibits the early phase of the PFC response, Ly-l-03 was 
added at time zero with  DNP-OVA to DNP-KLH-primed immune spleen cells FRIEDMAN  ET  AL. 
TABLE  II 
Interaction Between Ly-l-03 and B Cells Is I-A  a Restricted 
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Exp. No. 
1 
IgG anti-DNP PFC/culture of 
DNP-KLH-immune spleen cells 
Genetic restriction  BALB/cByJ*  A/J* 
Ly-l-03  971  833 
DNP-OVA  829  2,011 
DNP-OVA +  Ly-l-03  0  1,226 
2  H-2  d restriction  B10.D2nSnJ*  B10.ASgSnJ* 
Ly-l-03  826  1,762 
DNP-OVA  667  1,428 
DNP-OVA +  Ly-l-03  30  1,749 
3  I-A  d restriction  BALB/cByJ  BI0.GD 
Ly- 1-03  2,256  2,400 
DNP-OVA  2,616  2,675 
DNP-OVA +  Ly-l-03  239  29 
In  experiments  1 and  2,  DNP-KLH-immune spleen  cells of BALB/c, A]J, 
BI0.D2,  and  B10.A  were depleted  of most  adherent  cells by  two  90-min 
incubations of 5  ×  106 cells/ml on petri dishes.  The  nonadherent  immune 
spleen cells (106) were added to microwells containing adherent cells from 2.5 
X  105 (BALB/cJ X A/J)FI or (B10.D2  X BI0.A)FI nonimmune spleen cells. 
In  experiment  3,  the cultures contained  106 immune spleen cells of strain 
BALB/c or B10.GD.  In all three experiments, the cultures contained 0.10 
#g/ml DNP-KLH, 0.01  ttg/ml DNP-OVA, and  104 irradiated  Ly-l-03. lgG 
anti-DNP PFC were assayed on day 6. 
Plus (BALB/cJ x  A/J)F1 adherent cells. 
Plus (B10.D2 x  B10.A)F: adherent cells. 
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FIGURE 7.  The kinetics of inhibition of IgM and lgG PFC responses. Cultures contained 106 
immune spleen cells, 0.10 #g/ml DNP-KLH, 0.01  #g/ml DNP-OVA, and  104  Ly-l-03. The 
groups are DNP-KLH +  Ly-l-03 (O),  DNP-KLH +  DNP-OVA (O), and DNP-KLH +  DNP- 
OVA +  Ly-l-03 (0). IgM and IgG PFC anti-DNP were assayed daily from day 3 to 6. 
and the cultures were assayed for IgM and IgG anti-DNP PFC daily from day 3 
to day 6. IgM antibody synthesis was detected from day 3 to 5, and was 60-75% 
inhibited  in  the  presence  of both  DNP-OVA  and  clone  Ly-l-03,  (Fig.  7A). 796  B  CELL-Ly-1  T  CELL  INTERACTION  INHIBITS  IgG  RESPONSES 
Significant  number  of IgG  PFC  were detected  beginning  on day  4;  complete 
inhibition (95-100%) was seen in the presence of both DNP-OVA and clone Ly- 
1-03 on all days tested (days 3 to 6, Fig. 7B). 
We also tested whether  the time of addition  of the clone was important  for 
inhibition.  We added  104 irradiated  Ly-l-03 at 0,  24, 48, and 72 h  to separate 
cultures of immune spleen cells stimulated with DNP-KLH or DNP-OVA. When 
the clone was added at time 0, IgG PFC responses of DNP-OVA- but not DNP- 
KLH-stimulated  spleen cells were completely inhibited,  as tested at days 4-6. 
The clone inhibited  95% of PFC response when added  24 h after initiation  of 
culture, but did not inhibit when added at later times (Fig. 8). These data indicate 
that  the  Ly-I-B interaction  that  results in  B cell inactivation  must occur early 
(within the first 24 h) of the response. 
Short-term Incubation of B Cells with Clone Ly-l-03 Impairs their Ability to 
Differentiate Into IgG-secreting Plasma Cells 
To test whether the clones inactivated B cells before differentiation into IgG- 
secreting plasma  cells,  purified  B  cells from  DNP-KLH-immunized  mice were 
incubated with antigens and Ly-l-03 as indicated in Table III. At 48 h, Th cells 
and cloned Ly-l-03 T  cells were eliminated with anti-Thy-l.2,  -Ly-l.2, -Ly-2.2, 
and rabbit complement. After extensive washing, the B cells were cultured with 
KLH-specific Ly-1 Th cells and DNP-KLH for an additional 5 d, before assaying 
for an  anti-DNP  PFC  response.  Purified  B  cells that  were preincubated  with 
DNP-OVA and Ly-l-03 were irreversibly inhibited from secreting DNP-specific 
Ig. The inhibition of secretion by DNP-OVA and Ly-l-03 is antigen specific and 
dose  dependent;  maximum  inhibition  (89-95%)  occurred  when  B  cells  were 
cultured  with  0.01-0.10  •g/ml  DNP-OVA  (Table  III).  Inactivation  was  not 
caused  by cell  lysis;  on  the  contrary,  Ly-l-03  delivered an  early  proliferative 
signal  to the antigen-specific B memory cells.  Hapten-purified or DNP-binding 
B cells were activated by Ly-l-03 T  cells in the presence of the same low doses 
of DNP-OVA (data not shown). 
Time Ly 1- 03 AddKI 
FIGURE 8.  Ly-l-03 must be added between 0 and 24 h to DNP-OVA-stimulated cultures for 
complete inhibition of lgG PFC responses. 104 irradiated Ly-l-03 were added at time 0, 24, 
48, and 72 h  to immune spleen cells stimulated with either 0.01  #g/ml DNP-KLH or DNP- 
OVA. lgG PFC anti-DNP were assayed on days 4, 5, and 6. FRIEDMAN ET  AL.  797 
TABLE  III 
T Cell Clone Ly-1-03 Irreversibly Inhibits B Cell Secretion 
Incubation of B cells for 1st 48 h  Total anti-DNP 
PFC]culture 
Medium  816 
Medium + Ly-l-03 (104)  624 
DNP-KLH, 0.10 #g/ml  576 
DNP-KLH + Ly-l-03  1260 
DNP-OVA, 0.001 #g/ml  864 
DNP-OVA + Ly-l-03  34..8_8 
DNP-OVA, 0.01 #g/ml  648 
DNP-OVA + Ly-l-03  72 
DNP-OVA, 0.10 ug/ml  816 
DNP-OVA + Ly-l-03  48 
B plus accessory ceils from DNP-KLH-immune mice were incubated at 
time 0 with DNP-KLH, DNP-OVA, and 104 irradiated Ly-l-03, as indi- 
cated. At 48 h, the cultures were treated with anti-Thy-l.2 and anti-Ly- 
1.2 plus rabbit complement to remove the cloned T cells. On day 2, 2.5 
× 105 purified KLH-immune Ly-I spleen cells were added with 0.01 #g/ 
ml DNP-KLH to the precultured B plus accessory cells; 5 d later cultures 
were plaqued for total anti-DNP responses. 
Co-recognition  of an MHC (I-E) and a Non-MHC Molecule on B  Cells by Ly- 
1-03 Inhibits Secretion of Anti-DNP Ig 
The Ly-l-03 T  cell clone was also activated by I-E  d and a non-MHC-encoded 
antigen (X) present on  DBA/2  B  cells but not on (BALB/cByJ ×  DBA/2)F~  B 
cells (Friedman, S., D, Sillcocks, and H. Cantor, manuscript in preparation). The 
non-MHC-encoded molecule is a  B  cell-specific surface antigen not found on 
adherent  cells  (Fig.  9A).  Parenthetically,  stimulation  by  I-E  and  the  B  cell 
membrane determinant was less sensitive to irradiation than B cell presentation 
of soluble antigen. (Figs. 9A and 2A; 2,500 vs.  1,000 rad). The recognition of I- 
E d +  X  on DBA/2  B cells resulted in proliferation (Fig. 9A) and production of 
factors that induce proliferation of DBA/2 B cells (Fig. 9B), but did not induce 
polyclonal Ig secretion (data  not shown).  As few as  103  Ly-l-03 inhibited  IgG 
anti-DNP  secretion  by  DBA/2  B  cells  to  DNP-KLH  (Fig.  9C),  and  104  cells 
completely  suppressed  the  response.  The  efficiency  of  suppression  was  un- 
changed despite the absence of an antigen bridge to focus Ly-l-03 cells onto the 
correct (DNP  specific) B  memory cell.  Finally, (BALB/c ×  DBA/2)F~  B  cells, 
which do not express X and therefore do not activate Ly-1-03, were not inhibited 
to secrete IgG in the presence of Ly-l-03. 
Discussion 
Inhibition by Ly-1  T  Cell Clones.  These data provide the first direct evidence 
that at least some clones of inducer cells directly inhibit antibody secretion by B 
memory cells. The inhibitory function of these Ly-1 T  cell clones has been stable 798  B  CELL-Ly-I  T  CELL  INTERACTION  INHIBITS  IgG  RESPONSES 
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FmURE 9.  Though allo B cells activate Ly-l-03 and respond to growth factors produced by 
Ly-l-03, the B cells are inhibited to differentiate into IgG PFC by Ly-l-03. (A) B cells and not 
adherent cells  purified from normal DBA/2 spleen cells  activate Ly-l-03 to proliferate. Purified 
B cells were prepared from normal DBA/2 spleen cells as described in Materials  and Methods. 
Adherent cells were prepared by incubation of normal DBA/2 spleen cells for 60 min at 37°C. 
2.5 × 104 Ly-l-03 were added to increasing number of irradiated (2,500 rad) B cells (A) and 
adherent cells (O). (B) Activated Ly-l-03 induces the proliferation of DBA/2 B cells. 104 
irradiated Ly-l-03 were activated with 5 × 105 irradiated DBA/2J spleen cells, and increasing 
number of purified splenic DBA/2 B cells (A) were added. [3H]thymidine incorporation was 
assayed on day 2. (C) Ly-l-03 inhibits immune stimulated DBA/2 spleen cells from secreting 
IgG PFC anti-DNP in response to DNP-KLH. 106 immune spleen cells from DBA/2J (<>) and 
(BALB/cByJ X DBA/2J)FI (0)  mice were stimulated with 0.10 /~g/ml DNP-KLH and  an 
increasing number of nonirradiated (  ) or irradiated (- - -) clone Ly-l-03 cells were added 
at time 0. IgG anti-DNP PFC were assayed on day 6. 
over a  3  yr test period.  The inducer cell  must  be  focused onto the  B  cell by 
either a  soluble antigen bridge or a  B cell surface antigen, and requires recog- 
nition of B cell Ia (Tables I and II and Fig. 9 C).  Within 48 h or less, incubation 
of B cells with  Ly-1 T  cell clones and a  bridging antigen inhibited B cells from 
receiving helper signals  from immune  Ly-1  Th cells (Table III).  Inhibition  of 
IgG synthesis or secretion does not require that the Ly-I T  cell clones interact 
via antigen with antigen-specific Ig on the surface of B cells:  Ly-l-03 inhibited 
allogeneic  DBA/2  B  cells  from  responding  to  DNP-KLH  by interacting  with 
non-Ig B cell surface molecules (Fig.  9 C).  Inhibition of the secondary antibody 
responses in vitro does not require induction of T  suppressors.  Removal of Ly- 
2 + cells from the cultures by antibody and complement had no effect on inhibition 
(Fig.  4).  Inhibition  was  not  influenced by Ig-H-linked genes  (data  not  shown), 
unlike the induction of Ly-2  + suppressors (3, 33). 
Inhibition was seen at concentrations of antigen that do not induce prolifera- 
tion of the T  cell clone (compare Fig.  1 with 5 and 6). Irradiation had little effect 
on their suppressor function (Figs. 3 and 9 C), unlike Lyl :Qal  ÷ cells that paralyze 
B cells in the primary response to SRBC (4). 
There has been only one report of suppression of IgG antibody responses to 
soluble T-dependent antigens in vitro by Ly-1 T  cell clones (6). Asano and Hodes 
(6)  postulated  that  the  Ly-1  T  cell  clone  acts  by  interfering  with  the  MHC- 
restricted interaction between  Ly-1  T  helpers (in a  heterogeneous population) 
and B cells. Thus, if the clone recognizes one MHC-encoded molecule on F1  B 
cells,  only 25-50%  of helper activity (restricted to that  Ia  molecule) would be 
inhibited.  This is  not the case:  Clones restricted to  I-A  d completely inhibit the 
lgG  PFC response  to  DNP-KLH by (BALB/cJ ×  A/J)F~  spleen cells, although 
DNP-KLH was presented on I-A  d-, I-E  d-, I-A  k-, and I-Ek-encoded molecules (Fig. FRIEDMAN  ET  AL.  799 
6A and data not shown). Moreover, we failed to detect inhibition between cloned 
T  cells and  Ly-1  Th cells in  vitro, even when we attempted to link these two 
cells by an antigen bridge (Fig. 6B). These data strongly suggest that the target 
cell is the B cell rather than Ly-1 Th cells and that the inhibition is not mediated 
by interference with the positive interaction between B cells and Th cells. 
Lack of Helper Function.  Although these  Ly-1  T  cell clones fail  to  induce 
antigen-specific IgG secretion, they have some properties of inducer Ly-1 + T 
cells, including production of BCGF-1,  BCGF-2, and BCDF required for both 
primary anti-SRBC response and polyclonal stimulation of IgM secretion in anti- 
#-stimulated spleen cell cultures. The failure to help may be due to (a) lack of a 
specific BCDF required for IgG secretion (34) and/or (b) inhibition of secretion 
of B  cells.  Since  the  DNP-KLH-immune  spleen  cells  contain  all  the  factors 
required for the differentiation of IgG anti-DNP PFC, the second possibility is 
more likely. ~50% of antigen-specific inducer clones analyzed in this laboratory 
induce IgM but not IgG responses to proteins. Several of our investigators have 
derived T  cell clones that  do not induce IgG and have inhibitory activity as 
described. The frequency of these inhibitory clones among our nonhelper Ly-1 
T  cell lines is to be determined. 
Characteristics of Inhibition.  Effective inhibition at low antigen concentrations 
(0.001-0.10  #g/ml) requires cell contact between the Ly-1  T  cell clones and B 
cells. Supernatants derived from T  cell clones activated by antigen-pulsed adher- 
ent cells, or the supernatants enriched for antigen-binding material by affinity 
chromatography on  antigen-coupled  Sepharose  columns,  did  not  specifically 
inhibit DNP-immune B cells. If a  population  of 106  DNP-immune spleen cells 
contains ~103 DNP-specific B cells, then anywhere from 1- to 10 Ly-1  cloned T 
cells per immune B cell is sufficient for inhibition. This is also true for inhibition 
of PFC  responses of allogeneic (DBA/2) B  cells.  One would have expected a 
requirement for more cloned T  cells in  the latter case,  since all  nonimmune 
DBA/2  B  cells would be expected to display determinants recognized by the 
cloned  T  cells,  thus  preventing  efficient contact  with  DNP-specific  B  cells. 
Perhaps the DNP-KLH-activated B cells bind more avidly to Ly-1 T  cell clones 
because they express higher concentrations of (I-E  d +  X) on their surface (35). 
The Ly-1  T  cell clone may be brought into close contact with the B cells on 
the surface of antigen-presenting adherent cells (Fig. 5B) (20, 36), or via released 
vesicles and/or protein complexes containing Ia and antigen (37, 38). We favor 
direct interaction with B cells since recognition of I-E and a non-MHC surface 
component on B cells was sufficient for inhibition of the response (Fig.  9, A and 
C).  Inhibition by the  Ly-1  T  cell clones is not restricted to  the Lyb-5  + B cell 
subset (39);  the responses in  both  (BALB/c  X CBA/N)Fl  normal (Lyb-5  + and 
Lyb-5-) and (CBA/N  ×  BALB/c)F1  X-linked immune-deficient (xid)  (Lyb-5-) 
mice were equally inhibited (data not shown). 
Both T  cell clones inhibit IgG antibody responses to a greater extent than IgM 
responses.  In  >50  experiments,  IgG-specific responses were inhibited by  80- 
100%, whereas IgM-specific responses were either inhibited, unaffected, or even 
enhanced. We feel that the data are best explained by the affinity differences 
between the two classes of antibody (IgG, Kay  =  10 -7  M;  IgM, Kay >  10 -5 M) 
rather than by invoking isotype-restricted suppression (40). Thus, higher affinity 800  B  CELL-Ly-1  T  CELL  INTERACTION  INHIBITS  IgG  RESPONSES 
IgG antibodies would be  more efficient in  forming a  B  ceil-Ly-1  cell bridge 
required for inhibition. It is also unlikely that the Ly-1  T  cell clones caused the 
B  cells to  switcb  to a  class  of Ig not measured in  the PFC  assays (e.g.,  IgA); 
memory B cells committed to IgG synthesis apparently do not switch to another 
class of Ig (41, 42). 
This inducer-B cell interaction occurs early in the immune response, before 
differentiation of B cells into Ig-secreting cells. First, as soon as IgG secretion 
was detected in control cultures, on days 3 or 4, IgG secretion was inhibited in 
cultures containing antigen-activated Ly-1  T  cell clones (Fig.  7).  Second, incu- 
bation of DNP-immune B cells with antigen and the Ly-1 T  cell clone for 24-48 
h  prevented these B cells from receiving Th cell signals over the next 5 d  (Fig. 
8, Table III). 
Mechanism of B Cell Suppression.  T  cell clones did not lyse or inhibit prolif- 
eration of antigen-specific B cells during the early phase of the response. Nor do 
these Ly-1 T  cell clones lyse B cells, LPS blasts, or Ia-bearing tumor cells, when 
incubated with antigen (Fig.  9B and data not shown). A critical observation is 
that incubation of B cells with either clone resulted in antigen-dependent prolif- 
eration of antigen-specific B memory cells. Affinity-purified, DNP-specific B cells 
from DNP-KLH-immune spleen cells underwent a  substantial proliferative re- 
sponse 24-48 h after incubation with Ly-l-03 in the presence of low concentra- 
tions of DNP-OVA; after stimulation with low doses of antigen, the clone does 
not produce nonspecific B cell proliferative responses (data not shown). Thus, 
Ly-l-03  induces  an  early  proliferative  response  of DNP-specific  B  cells,  but 
inhibits subsequent antibody secretion. 
The negative signal imparted by the  Ly-1  T  cell clones in  the presence of 
soluble antigens is  unusual  in  that  it  inactivates adult B  cells to  conventional 
antigens like  DNP3OVA  or ARSaOVA.  Tolerance of B  cells usually requires 
contact with antigens that present a polyvalent matrix to B cells like DNP-SIII 
(pneumococcal polysaccharide) or unusual antigens like haptenated Ig vs.  hap- 
tenated BSA (43-45). The gamma globulins are unique tolerogens in that they 
can impart negative signals to B cells via Fc receptor binding (46). We have used 
a  conventional antigen (e.g., DNP3OVA) at concentrations (_10 -9 M) that are 
100-1,000-fold less than usually required to inhibit adult B cells by equivalently 
haptenated Ig (45). The inactivating molecule is not the antigen-binding T  cell 
receptor secreted by  Ly-1  T  cell  clones.  On  the  contrary,  whereas antigen- 
binding material secreted by a TNP-specific Ly-1  T  cell clone provides positive 
signals for B cell maturation and IgM secretion (47, 48), the same T  cell clone 
inhibits the secretion of IgG when it makes an antigen-specific and I  region- 
restricted contact with  B  cells  (data  not  shown).  If receptor blockade  is  the 
mechanism of inactivation by the clones, then the molecules causing the blockade 
are bound so tightly to the Ig receptor that they can not be removed by extensive 
washing (Table III). If, instead, the T  cell clones cause receptor modulation of 
B  cells,  then the  T  cell  must  present  the antigen bound  to  its  receptor in  a 
bivalent or multivalent complex that leads to patching, capping, and endocytosis 
of membrane Ig receptor (43). 
It is possible that the Ly-1 T cell clone releases factors (49) (other than antigen- 
binding factors) that impart a negative signal only to the B cell with which it has FRIEDMAN  ET  AL.  801 
previously made the antigen-specific and MHC-restricted contact. Whatever the 
negative signal may be, it cannot be neutralized by LPS, a polyclonal activator 
of B cells (data not shown; 50). 
Relevance to the In Vivo Immune Response.  These T  cell clones can also inhibit 
secondary antibody responses  in  vivo.  Secondary IgG anti-DNP  responses  of 
mice immunized with DNP-KLH were inhibited by simultaneous injection of 
clone Ly-l-03 and DNP-OVA, or to a lesser extent with OVA (Friedman, S., D. 
Sillcocks, and H. Cantor, manuscript in preparation).  Ly-1  T  cells with similar 
function to Ly-l-03 may regulate physiological antibody responses to DNP-OVA 
by one of two mechanisms. As the immune response progresses,  more B cells 
with higher affinity antibody will be selected and thus more of these B cells may 
be inactivated by antigen-specific suppressor  Ly-1  T  cells.  Alternatively, these 
Ly-1  T  cells  may expand  a  population  of antigen-specific B  cells  to  become 
memory B cells that are refractory to secretion until the next antigenic challenge. 
Analysis of inducer T  cell clones thus indicates that the set of Ly-1/OKT4  + T 
cells may include cells that differentially  regulate B cell activation and maturation 
(51, 52).  Further studies should help to clarify the role of each in the production 
of appropriate immune responses to foreign and autoiogous proteins. 
Summary 
We find that a fraction of Ly-1 +2- inducer T cell clones inhibits differentiation 
of memory B cells into IgG-secreting plaque-forming cells.  Inhibition of second- 
ary antibody responses was not the result of induction of Ly-2  + T  suppressors. 
Instead, inducer cells directly inactivated B cells, requiring an antigen bridge as 
well as identity at the major histocompatibility complex (I-A)  locus. The inter- 
action  between  the  inducer T  cell  clone and  hapten-specific B  memory cells 
results in  an early proliferative response and subsequent  failure of B  cells to 
secrete antibody in response to T  helper cell signals.  Possible mechanisms for 
this novel type of B cell inactivation are explored. 
We thank Patricia AI-Kotob and Minou Modabber for their expert assistance in prepara- 
tion of this manuscript. 
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